1. Home
  2. ACET vs GAIA Comparison

ACET vs GAIA Comparison

Compare ACET & GAIA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Adicet Bio Inc.

ACET

Adicet Bio Inc.

HOLD

Current Price

$7.86

Market Cap

77.3M

Sector

Health Care

ML Signal

HOLD

Logo Gaia Inc.

GAIA

Gaia Inc.

HOLD

Current Price

$2.41

Market Cap

70.9M

ML Signal

HOLD

Company Overview

Basic Information
Metric
ACET
GAIA
Founded
1947
1988
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Movies/Entertainment
Sector
Health Care
Consumer Discretionary
Exchange
Nasdaq
Nasdaq
Market Cap
77.3M
70.9M
IPO Year
2017
1999

Fundamental Metrics

Financial Performance
Metric
ACET
GAIA
Price
$7.86
$2.41
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
3
1
Target Price
$48.33
$6.50
AVG Volume (30 Days)
83.4K
72.2K
Earning Date
05-06-2026
05-04-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
18.18
EPS
N/A
N/A
Revenue
N/A
$4,500,000.00
Revenue This Year
N/A
$13.07
Revenue Next Year
N/A
$12.04
P/E Ratio
N/A
N/A
Revenue Growth
N/A
12.50
52 Week Low
$0.46
$2.30
52 Week High
$9.05
$6.39

Technical Indicators

Market Signals
Indicator
ACET
GAIA
Relative Strength Index (RSI) 51.03 41.15
Support Level $7.50 $2.37
Resistance Level $8.68 $3.41
Average True Range (ATR) 0.53 0.19
MACD -0.10 -0.02
Stochastic Oscillator 44.75 13.78

Price Performance

Historical Comparison
ACET
GAIA

About ACET Adicet Bio Inc.

Adicet Bio Inc is a clinical-stage biotechnology company discovering and developing allogeneic gamma delta T cell therapies for autoimmune diseases and cancer. It is advancing a pipeline of off-the-shelf gamma delta T cells, engineered with chimeric antigen receptors (CARs), to facilitate durable activity in patients. The company's main product candidate, prulacabtagene leucel (prula-cel), is an allogeneic gamma delta T cell therapy expressing a CAR targeting CD20, and is being developed for the potential treatment of autoimmune diseases. Additionally, it is pursuing ADI-212, a next-generation gene-edited and armored clinical candidate designed to target prostate-specific membrane antigen (PSMA).

About GAIA Gaia Inc.

Gaia Inc is a video streaming service and community that provides curated conscious media in primary channels; Seeking Truth provides new and enlightening perspectives for today's changing world; Transformation provides a wealth of content in the niche areas of spiritual growth, personal development, and expanded consciousness; Alternative Healing channel features content focused on food and nutrition, holistic healing, alternative and integrative medicines, and longevity, and Yoga. The company operates in a single reporting segment. Its revenues is derived from subscription fees for services related to streaming content to the members. Geographically, it derives a majority of its revenue from the United States and also has an International presence.

Share on Social Networks: